EU asserts generic drug exports exempt from proposed US tariffs

The European Commission claims that generic pharmaceutical exports to the U.S. remain protected under the 2025 Turnberry trade agreement. It remains uncertain whether the incoming U.S. administration will honor this bilateral framework or attempt to override it with new protectionist measures.